WallStSmart
VALN

Valneva SE ADR

NASDAQ: VALN · HEALTHCARE · BIOTECHNOLOGY

$5.38
+0.94% today

Updated 2026-04-30

Market cap
$480.43M
P/E ratio
P/S ratio
2.75x
EPS (TTM)
$-1.59
Dividend yield
52W range
$5 – $12
Volume
0.1M

Valneva SE ADR (VALN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+5.3%
Last 4 quarters
Revenue YoY growth
-9.9%
Most recent quarter
EPS YoY growth
-23.8%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.8%
2026-03-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.67-81.8%$11.19$10.32-7.8%
2025-11-20$-0.50-50.2%$8.70$8.62-0.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.37$-0.67-81.8%$47.69M-9.9%
2025-09-30$-0.33$-0.50-50.2%$29.41M-35.8%
2025-06-30$-0.39$-0.07+81.9%$48.33M+27.0%
2025-03-31$-0.21$-0.06+71.1%$49.23M+50.3%
2024-12-31$-0.17$-0.54-228.8%$52.94M+26.4%
2024-09-30$-0.28$-0.07+75.0%$45.82M+20.4%
2024-06-30$-0.27$-0.34-25.9%$38.06M-5.4%
2024-03-31$0.87$0.82-5.7%$32.75M-2.3%
2023-12-31$0.11$-0.46-518.2%$41.90M
2023-09-30$0.13$-0.50-484.6%$38.07M
2023-06-30$-0.23$-0.24-4.3%$40.23M
2023-03-31$-0.21$-0.13+38.1%$33.51M
2022-12-31$-0.50$-0.41+18.6%

Frequently asked questions

Has Valneva SE ADR beaten earnings estimates?
Valneva SE ADR has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +5.3% over the last 4 quarters.
How does VALN stock react to earnings?
VALN stock has moved an average of -4.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Valneva SE ADR's revenue growth rate?
Valneva SE ADR reported year-over-year revenue growth of -9.9% in its most recent quarter, with EPS growing -23.8% year-over-year.